employer cover photo
employer logo
employer logo

Candel Therapeutics

Is this your company?

Candel Therapeutics reviews

4.3

76% would recommend to a friend

(10 total reviews)

Paul Peter Tak, MD PhD FMedSci

82% approve of CEO

59% positive business outlook

Reviews by job title

10 reviews
3.0
Jun 5, 2023

Upbeat morale and culture doesn’t compensate for burnout

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Candel has (for the most part) a positive and employee-focused environment. Company events are frequently scheduled to encourage a friendly and social environment with coworkers. Hybrid work policy is in full swing and there does not appear to be an end in sight to that. The CEO and leadership are transparent and trustworthy. Flexible PTO policy is a huge draw to the company. Overall they believe strongly in their product and their message which is very encouraging.

Cons

Leadership and management can be overly positive and turn a blind eye to employee burnout, even when it is repeatedly brought to their attention. Tasks are often inappropriately delegated to employees who do not function in that role, and workloads are unevenly distributed amongst team members. Despite the additional tasks delegated, there is little opportunity for growth, as if taking on these tasks is simply the expectation without reward or recognition. Resources are also unevenly delegated to important projects which puts a strain on employees delegated to those projects. When an employee leaves, their work is sometimes distributed amongst their coworkers rather than hiring a new employee to take on that work, which increases burnout. Meetings are excessive and subject matter is often superfluous and unnecessary.

5.0
Mar 28, 2022
Recommend
CEO approval
Business Outlook

Pros

As a frame of reference, I have worked in various roles at different pharma/ biotech companies for more than 10 years. Candel's positive culture stands out. The CEO and leadership team has placed an emphasis on fostering a positive culture. At the grass roots level, team members genuinely care about each other, take an active role in shaping the company culture, and are passionate about their work. As a small company, there are not a lot of layers between the bench scientists and the leadership team, and the leadership team has an open door policy for feedback, which has been supported by group feedback sessions, town halls, etc. Importantly, it feels like feedback is heard and acted upon. The team has grown considerably over the past 12 months, and we have built up our in-house capabilities in many key functions. Management has also been very supportive of professional development for team members who have been with Candel since its early days; it feels like opportunity is only limited by one's motivation to grow. Over the past year, there has been major progress in making the company competitive on benefits, specifically with better health insurance coverage, addition of 401k (and company match), updated bonus targets, and vacation policy, which are now in line with other biotechs / pharma. The company's mission, which is to save, extend and improve the lives of patients with cancer through oncolytic viral immunotherapies, is one I'm proud (and humbled) to help advance. Like so many, I have had close friends and family members affected by cancer, and my team members feel passionate about their job for the same reason.

Cons

There have been some growing pains as the company has transitioned to a publicly traded company with a maturing pipeline that includes Ph3 studies with registration intent. Specifically, there has been a need to update processess, SOPs, and systems to support GxP practices (GMP, GCP, GDP) and anticipated regulatory filings, and there has been an ongoing roll out of trainings, new systems, documentation practices, etc. Given that the team is still comparatively small, and there is not the full depth of specialization one finds at a large pharma, so it definitely helps to have a 'roll up the sleeves' attitude to pitch in where and when needs arise. As with any biotech, the team is busy and there is pressure to deliver on our objectives. In the meantime, there are some roles / functions that are still being filled, so these aspects should continue to improve as our team and capabilities grow. Overally, I think management has done a good job of supporting work-life balance for employees, and management has been very intentional to build an organization and culture that can deliver sustainable excellence.

5.0
Mar 8, 2022

Good Trajectory

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

-Extraordinarily positive corporate culture. CEO takes highly functional team dynamics seriously. -Often cited leadership traits of honesty, competency, being forward looking and being inspirational are all in evidence with current CEO who started in 2020 -Late stage randomized clinical trials completely enrolled. Also an early clinical asset. -Professional capability in place at all levels of the company. -Transparency and accountability are embedded in leaderships actions -Recently increased emphasis on underlying biology and discovery work -Evidence of opportunities for career advancement provided to employees

Cons

-Stock price has been hammered since the IPO. But that could translate to more upside for those joining the company now.

Viewing 1 - 3 of 10 Reviews

Glassdoor has 11 Candel Therapeutics reviews submitted anonymously by Candel Therapeutics employees. Read employee reviews and ratings on Glassdoor to decide if Candel Therapeutics is right for you.